March 27, 2007 (New Orleans) — Post hoc analysis of data from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study shows that the risk for coronary artery disease events ...

An international team of researchers has completed a study that showed that Lipitor (atorvastatin calcium) reduced secondary strokes by 16 percent and major coronary events by 35 percent. Because ...

The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial showed that, in patients who had experienced a stroke or transient ischemic attack, treatment with high-dose ...

In the United States, someone suffers a stroke every 40 seconds, and someone dies from a stroke every four minutes. Statin therapy can reduce the risk of ischemic stroke, which comprises 87% of all ...

DURHAM, N.C. -- In people who have experienced a stroke, but who have no known history of coronary heart disease, beginning regular treatment with the cholesterol-lowering drug atorvastatin soon after ...

Treatment with statins has been reported to reduce the risk of stroke in patients with coronary heart disease (CHD). Whether patients without CHD who have suffered a previous stroke or transient ...

Patients who have suffered one stroke can dramatically reduce their chances of having a second by taking a statin drug such as Pfizer’s Lipitor, according to the results of the large-scale SPARCL ...

The risk of recurrent stroke is reduced by 16%, in people who have no known history of coronary heart disease and start on a regular treatment with atorvastatin, a cholesterol-lowering drug. According ...

NEW YORK (Reuters Health) - The use of cholesterol-lowering "statin" drugs, such as Lipitor (atorvastatin) and Zocor (simvastatin), may raise the risk of brain hemorrhage in patients who have ...

NORTH CHICAGO, ILL. (August 10, 2006) – According to data from the National Stroke Association, up to 40 percent of patients who have had a stroke will experience a second stroke within five years of ...

According to a five-year study led by an international team that includes a researcher at Duke University Medical Center, the risk of recurrent stroke is reduced by 16%, in people who have no known ...